Poly(ADP-ribose) polymerase 1 (PARP1) overexpression in human breast cancer stem cells and resistance to olaparib
- PMID: 25144364
- PMCID: PMC4140711
- DOI: VSports注册入口 - 10.1371/journal.pone.0104302
Poly(ADP-ribose) polymerase 1 (PARP1) overexpression in human breast cancer stem cells and resistance to olaparib
Abstract
Background: Breast cancer stem cells (BCSCs) have been recognized as playing a major role in various aspects of breast cancer biology. To identify specific biomarkers of BCSCs, we have performed comparative proteomics of BCSC-enriched and mature cancer cell populations from the human breast cancer cell line (BCL), BrCA-MZ-01 VSports手机版. .
Methods: ALDEFLUOR assay was used to sort BCSC-enriched (ALDH+) and mature cancer (ALDH-) cell populations. Total proteins were extracted from both fractions and subjected to 2-Dimensional Difference In-Gel Electrophoresis (2-D DIGE) V体育安卓版. Differentially-expressed spots were excised and proteins were gel-extracted, digested and identified using MALDI-TOF MS. .
Results: 2-D DIGE identified poly(ADP-ribose) polymerase 1 (PARP1) as overexpressed in ALDH+ cells from BrCA-MZ-01. This observation was confirmed by western blot and extended to four additional human BCLs. ALDH+ cells from BRCA1-mutated HCC1937, which had the highest level of PARP1 overexpression, displayed resistance to olaparib, a specific PARP1 inhibitor V体育ios版. .
Conclusion: An unbiased proteomic approach identified PARP1 as upregulated in ALDH+, BCSC-enriched cells from various human BCLs, which may contribute to clinical resistance to PARP inhibitors. VSports最新版本.
Conflict of interest statement
Competing Interests: The authors have read the journal’s policy and have the following conflicts: This work was supported by a grant from Sanofi-Aventis. The authors declare that they have no other conflict of interest V体育平台登录. The authors confirm that this does not alter their adherence to PLOS ONE policies on sharing data and materials.
Figures
References
-
- Wicha MS, Liu S, Dontu G (2006) Cancer stem cells: an old idea–a paradigm shift. Cancer Res 66: 1883–1890. - PubMed
-
- Dean M, Fojo T, Bates S (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5: 275–284 10.1038/nrc1590 - DOI (V体育2025版) - PubMed
-
- Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, et al. (2009) Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 69: 1302–1313. - PMC (V体育平台登录) - PubMed
Publication types
MeSH terms
- VSports手机版 - Actions
- "VSports在线直播" Actions
- Actions (VSports在线直播)
- Actions (VSports)
"VSports在线直播" Substances
- "VSports最新版本" Actions
- Actions (V体育2025版)
- "V体育官网" Actions
VSports在线直播 - LinkOut - more resources
"V体育2025版" Full Text Sources
Other Literature Sources (VSports)
Medical
"V体育官网" Miscellaneous
